MARIETTA, Ga. — Solvay Pharmaceuticals has narrowed its lists of finalists for a $300 million vaccine plant to North Carolina, Georgia, New York and Alabama, according to media reports.
For example, newspapers in Alabama say that state is a finalist for what Alabama officials are calling “Project Bamboo.”
Solvay operates out of Marietta and is a subsidiary of the Belgium-based company Solvay SA. It is expected to pick a plant location early this summer.
North Carolina landed a vaccine plant from Novartis that is being built to meet contracts awarded by the federal government for flu vaccine production. The Novartis facility will be built in Apex.
Related Items
Solvay Pharmaceuticals Considers N.C., Georgia for $300M Vaccine Plant
Copyright 2009 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Updated Jul. 3 7:42 a.m. - As Nortel’s final demise nears, what blame should its board shoulder?
Posted Jul. 3 7:03 a.m. - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Posted Jul. 3 6:43 a.m. - 20/20: Surgery can let you see like a child again
Posted Jul. 3 6:29 a.m. |
- CDC: US swine flu cases rise to nearly 34,000
Updated Jul. 3 6:30 a.m.
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement